Connection

Kevin Gray to Substance-Related Disorders

This is a "connection" page, showing publications Kevin Gray has written about Substance-Related Disorders.
Connection Strength

3.957
  1. Cannabis Use Disorder in Adolescents. Child Adolesc Psychiatr Clin N Am. 2023 01; 32(1):13-20.
    View in: PubMed
    Score: 0.435
  2. Adolescent Substance Use Disorder Treatment: an Update on Evidence-Based Strategies. Curr Psychiatry Rep. 2019 09 14; 21(10):96.
    View in: PubMed
    Score: 0.351
  3. Youth Substance Use: Introduction to the Journal of Child and Adolescent Psychopharmacology Special Issue. J Child Adolesc Psychopharmacol. 2019 08; 29(7):475-476.
    View in: PubMed
    Score: 0.348
  4. Pharmacological Treatment of Youth Substance Use Disorders. J Child Adolesc Psychopharmacol. 2019 08; 29(7):559-572.
    View in: PubMed
    Score: 0.342
  5. Methods to reduce the incidence of false negative trial results in substance use treatment research. Curr Opin Psychol. 2019 12; 30:35-41.
    View in: PubMed
    Score: 0.336
  6. Research Review: What have we learned about adolescent substance use? J Child Psychol Psychiatry. 2018 06; 59(6):618-627.
    View in: PubMed
    Score: 0.302
  7. Neuroimaging the neural correlates of increased risk for substance use disorders in attention-deficit/hyperactivity disorder-A systematic review. Am J Addict. 2017 Mar; 26(2):99-111.
    View in: PubMed
    Score: 0.292
  8. Personalizing substance use treatment based on pre-treatment impulsivity and sensation seeking: A review. Drug Alcohol Depend. 2016 Oct 01; 167:1-7.
    View in: PubMed
    Score: 0.283
  9. Alcohol and Drug Use and the Developing Brain. Curr Psychiatry Rep. 2016 May; 18(5):46.
    View in: PubMed
    Score: 0.278
  10. Potential role of N-acetylcysteine in the management of substance use disorders. CNS Drugs. 2014 Feb; 28(2):95-106.
    View in: PubMed
    Score: 0.238
  11. Cigarette and cannabis use trajectories among adolescents in treatment for attention-deficit/hyperactivity disorder and substance use disorders. Drug Alcohol Depend. 2011 Sep 01; 117(2-3):242-7.
    View in: PubMed
    Score: 0.195
  12. Advances in diagnosis of adolescent substance abuse. Adolesc Med Clin. 2006 Jun; 17(2):411-25.
    View in: PubMed
    Score: 0.140
  13. The estimand framework and its application in substance use disorder clinical trials: a case study. Am J Drug Alcohol Abuse. 2021 11 02; 47(6):658-663.
    View in: PubMed
    Score: 0.102
  14. Substance use patterns in 9-10 year olds: Baseline findings from the adolescent brain cognitive development (ABCD) study. Drug Alcohol Depend. 2021 10 01; 227:108946.
    View in: PubMed
    Score: 0.100
  15. Latency to cannabis dependence mediates the relationship between age at cannabis use initiation and cannabis use outcomes during treatment in men but not women. Drug Alcohol Depend. 2021 01 01; 218:108383.
    View in: PubMed
    Score: 0.095
  16. A Double-Blind, Randomized, Controlled Pilot Trial of N-Acetylcysteine in Veterans With Posttraumatic Stress Disorder and Substance Use Disorders. J Clin Psychiatry. 2016 Nov; 77(11):e1439-e1446.
    View in: PubMed
    Score: 0.072
  17. Cognitive enhancers in the treatment of substance use disorders: clinical evidence. Pharmacol Biochem Behav. 2011 Aug; 99(2):285-94.
    View in: PubMed
    Score: 0.049
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.